HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hortensia Alonso-Navarro Selected Research
Hortensia Alonso-Navarro Research Topics
Disease
22
Parkinson Disease (Parkinson's Disease)
06/2022 - 01/2008
20
Essential Tremor (Essential Tremors)
06/2022 - 01/2006
13
Migraine Disorders (Migraine)
06/2022 - 09/2005
12
Restless Legs Syndrome (Restless Legs)
01/2022 - 04/2013
9
Tremor (Tremors)
01/2020 - 01/2006
7
Multiple Sclerosis
11/2020 - 09/2010
3
Parkinsonian Disorders (Parkinsonism)
06/2022 - 01/2014
3
Epilepsy (Aura)
01/2020 - 07/2017
3
Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
02/2016 - 01/2013
2
Neurodegenerative Diseases (Neurodegenerative Disease)
06/2022 - 01/2015
2
Multiple System Atrophy
06/2022 - 03/2013
2
Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
06/2022 - 03/2013
2
Lewy Body Disease (Lewy Body Dementia)
06/2022 - 08/2021
2
Nervous System Diseases (Neurological Disorders)
06/2022 - 01/2021
2
Peripheral Nervous System Diseases (PNS Diseases)
01/2021 - 07/2008
2
Inflammation (Inflammations)
11/2020 - 01/2016
2
Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
03/2015 - 05/2006
2
Drug-Related Side Effects and Adverse Reactions
01/2014 - 01/2012
2
Movement Disorders (Movement Disorder)
04/2013 - 01/2008
2
Ataxia (Dyssynergia)
01/2013 - 02/2011
2
Bruxism
07/2011 - 03/2009
2
Blepharospasm
11/2006 - 07/2006
2
Migraine without Aura (Common Migraine)
05/2006 - 09/2005
1
Synucleinopathies
11/2021
1
Polyneuropathies (Polyneuropathy)
01/2021
1
Charcot-Marie-Tooth Disease (Peroneal Muscular Atrophy)
01/2021
1
Disorders of Excessive Somnolence (Hypersomnia)
01/2021
1
Sepsis (Septicemia)
11/2020
1
COVID-19
11/2020
1
Neuroinflammatory Diseases
11/2020
1
Chronic Hepatitis C
11/2020
1
Respiratory Tract Diseases (Respiratory Tract Disease)
11/2020
1
Spinal Cord Injuries (Spinal Cord Injury)
11/2020
1
Sleepiness
01/2020
1
Tourette Syndrome (Tourette's Syndrome)
01/2019
1
Vitamin D Deficiency
01/2019
1
Cataplexy
08/2016
Drug/Important Bio-Agent (IBA)
8
Enzymes
IBA
08/2016 - 01/2008
8
Biomarkers (Surrogate Marker)
IBA
02/2014 - 01/2012
7
Histamine (Histamine Dihydrochloride)
FDA Link
06/2022 - 01/2008
7
Nitric Oxide (Nitrogen Monoxide)
FDA Link
01/2021 - 06/2015
6
Ethanol (Ethyl Alcohol)
IBA
01/2020 - 07/2007
5
Calcitriol Receptors (Calcitriol Receptor)
IBA
06/2022 - 01/2013
5
Proteins (Proteins, Gene)
FDA Link
01/2021 - 01/2014
5
gamma-Aminobutyric Acid (GABA)
IBA
01/2018 - 02/2011
4
Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))
IBA
02/2019 - 07/2007
4
GABA Receptors (GABA Receptor)
IBA
01/2018 - 02/2011
4
Heme Oxygenase-1
IBA
02/2016 - 01/2014
3
Carrier Proteins (Binding Protein)
IBA
06/2022 - 04/2021
3
Vitamin D
FDA Link
Generic
04/2021 - 01/2013
3
mesoglycan
IBA
01/2021 - 07/2016
3
Iron
IBA
01/2021 - 01/2007
3
Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)
IBA
01/2021 - 01/2020
3
Transferases
IBA
01/2017 - 10/2008
3
Amino Acid Transport System X-AG (Glutamate Transporter)
IBA
11/2015 - 11/2013
3
Pharmaceutical Preparations
IBA
01/2014 - 05/2006
3
Aryldialkylphosphatase (Paraoxonase)
IBA
09/2010 - 08/2010
3
Topiramate (Topamax)
FDA Link
Generic
07/2008 - 05/2006
2
coenzyme Q10 (CoQ10)
IBA
06/2022 - 10/2010
2
Amine Oxidase (Copper-Containing)
IBA
06/2022 - 02/2015
2
Acids
IBA
01/2018 - 07/2017
2
Heme (Haem)
IBA
05/2017 - 02/2016
2
Xenobiotics
IBA
08/2016 - 01/2014
2
Histamine N-Methyltransferase
IBA
07/2016 - 01/2008
2
Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)
IBA
10/2015 - 06/2015
2
Glutamic Acid (Glutamate)
FDA Link
03/2014 - 02/2014
2
ropinirole (Requip)
FDA Link
Generic
07/2013 - 07/2009
2
Dopamine D3 Receptors
IBA
04/2013 - 10/2009
2
Antidepressive Agents (Antidepressants)
IBA
03/2009 - 05/2006
2
Primidone (Sertan)
FDA Link
Generic
07/2008 - 01/2006
2
Gabapentin (Neurontin)
FDA Link
Generic
07/2008 - 05/2007
2
Propranolol (Inderal)
FDA Link
Generic
07/2008 - 05/2006
2
Cytochrome P-450 CYP2C19
IBA
05/2006 - 01/2006
2
Anticonvulsants (Antiepileptic Drugs)
IBA
05/2006 - 05/2006
1
Vitamin D-Binding Protein
IBA
06/2022
1
Trace Elements (Biometals)
IBA
01/2022
1
Zinc
IBA
01/2022
1
alpha-Synuclein
IBA
08/2021
1
Genetic Markers (Genetic Marker)
IBA
05/2021
1
25-hydroxyvitamin D
IBA
04/2021
1
Biological Products
IBA
01/2021
1
Amyloid (Amyloid Fibrils)
IBA
01/2021
1
Amantadine (Aman)
FDA Link
Generic
11/2020
1
Lipopolysaccharides
IBA
11/2020
1
Memantine (Namenda)
FDA Link
11/2020
1
Sphingosine-1-Phosphate Receptors
IBA
01/2020
1
T-Type Calcium Channels (T-Type Calcium Channel)
IBA
01/2020
1
Cannabinoid Receptor Antagonists
IBA
01/2020
1
Harmaline
IBA
01/2020
1
Synucleins
IBA
01/2019
1
Opiate Alkaloids
IBA
01/2019
1
GABA-B Receptors
IBA
07/2017
1
Hydro-Lyases (Dehydratases)
IBA
05/2017
1
levulinic acid (magnesium levulinate)
IBA
05/2017
1
Lamotrigine (Lamictal)
FDA Link
Generic
08/2016
1
Oxygenases
IBA
02/2016
1
Heme Oxygenase (Decyclizing) (Heme Oxygenase)
IBA
06/2015
1
Diamines
IBA
02/2015
1
Catechol O-Methyltransferase (Methyltransferase, Catechol)
IBA
07/2014
Therapy/Procedure
10
Therapeutics
11/2021 - 07/2006